These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The BCTRIMS expanded consensus on treatment of multiple sclerosis: II. The evidences for the use of glucocorticoids and immunomodulatory treatments].
    Author: Moreira MA, Lana-Peixoto MA, Callegaro D, Haussen SR, Gama PD, Gabbai AA, Rocha FC, Lino AM, Participantes da Reunião do Consenso Expandido sobre Tratamento da Esclerose Múltipla do Comitê Brasileiro de Tratamento e Pesquisa em Esclerose Múltipla (BCTRIMS).
    Journal: Arq Neuropsiquiatr; 2002 Sep; 60(3-B):875-80. PubMed ID: 12364966.
    Abstract:
    Multiple sclerosis is an inflammatory disease in which immunological mechanisms play an important role in causing demyelinating lesions in the central nervous system. A number of drugs acting in different stages of these mechanisms have been tested for its treatment. This paper analyses the most important clinical trials with glucocorticoids and immunomodulatory treatments, including human immunoglobulin, using the classes of evidences and types of recommendations as have been defined and widely accepted by the international scientific community. It aims to provide sufficient information to support the BCTRIMS Expanded Consensus on Treatment of MS.
    [Abstract] [Full Text] [Related] [New Search]